Topical Menaquinone-7(Vitamin K2, MK-7) asa Mitochondrial Bioenergetic Activator for Skin Anti-Aging: MechanisticEvidence in Skin Cells and a Randomized Split-Face/Neck Study

Abstract Mitochondrial dysfunction contributes to skin aging by limiting cellular energy supply, shifting redox balance, and amplifying oxidative injury, which together favor extracellular matrix breakdown and loss of tissue mechanics. Vitamin K2 (menaquinone-7; MK-7) has been proposed to support mitochondrial electron transport, yet its bioenergetic activity in the skin and its effects on aging-related outcomes remain insufficiently characterized. To evaluate whether MK-7 can improve mitochondrial bioenergetics in skin-relevant cells under oxidative stress and whether these effects translate into quantifiable anti-aging benefits in a controlled human study. In vitro, human skin cells were exposed to UVA or hydrogen peroxide to model oxidative stress and then treated with MK-7. ATP content, NAD+/NADH ratio, mitochondrial membrane potential (ΔΨm), mitochondrial DNA (mtDNA) copy number, respiratory chain complex activities (I–V), and senescence-associated secretory phenotype (SASP) expression were assessed using established assays. In vivo, a randomized, double-blind, split-face/neck, vehicle-controlled trial enrolled women aged 35–60 years (n = 30 completers). Participants applied a 0.05% MK-7 face-and-neck cream to one randomized side and placebo to the contralateral side twice daily for 8 weeks. Wrinkles/roughness, elasticity, and sagging were instrumentally quantified at baseline and weeks 2, 4, and 8. MK-7 increased ATP production, elevated the NAD+/NADH ratio, restored ΔΨm, preserved mtDNA copy number under oxidative challenge, enhanced activities of multiple respiratory complexes, and reduced UVA-induced SASP marker expression. In human efficacy evaluations, MK-7 produced significant improvements versus placebo in wrinkle roughness on face and neck, improved elasticity parameters, and attenuated sagging over 8 weeks. MK-7 was associated with improved mitochondrial bioenergetic readouts in vitro and measurable anti-aging effects in a split-face/neck study, supporting further development of mitochondrial targeting approaches for skin aging.

Authors

Institutions

Publication Details

Journal
ACS Omega
Published
2026-08-14
DOI
https://doi.org/10.1021/acsomega.6c03314
Primary Topic
Vitamin K Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Topical Menaquinone-7(Vitamin K2, MK-7) asa Mitochondrial Bioenergetic Activator for Skin Anti-Aging: MechanisticEvidence in Skin Cells and a Randomized Split-Face/Neck Study

Ruijing Wei, Meijing Wang, Yanan Li, He Huang et al.
ACS Omega
Vitamin K Research Studies
article

Topical Menaquinone-7(Vitamin K2, MK-7) asa Mitochondrial Bioenergetic Activator for Skin Anti-Aging: MechanisticEvidence in Skin Cells and a Randomized Split-Face/Neck Study

Ruijing Wei, Meijing Wang, Yanan Li, He Huang, Chen Liu, Shilan Zhao, Chunxiao Xu
article en

Abstract

Abstract Mitochondrial dysfunction contributes to skin aging by limiting cellular energy supply, shifting redox balance, and amplifying oxidative injury, which together favor extracellular matrix breakdown and loss of tissue mechanics. Vitamin K2 (menaquinone-7; MK-7) has been proposed to support mitochondrial electron transport, yet its bioenergetic activity in the skin and its effects on aging-related outcomes remain insufficiently characterized. To evaluate whether MK-7 can improve mitochondrial bioenergetics in skin-relevant cells under oxidative stress and whether these effects translate into quantifiable anti-aging benefits in a controlled human study. In vitro, human skin cells were exposed to UVA or hydrogen peroxide to model oxidative stress and then treated with MK-7. ATP content, NAD+/NADH ratio, mitochondrial membrane potential (ΔΨm), mitochondrial DNA (mtDNA) copy number, respiratory chain complex activities (I–V), and senescence-associated secretory phenotype (SASP) expression were assessed using established assays. In vivo, a randomized, double-blind, split-face/neck, vehicle-controlled trial enrolled women aged 35–60 years (n = 30 completers). Participants applied a 0.05% MK-7 face-and-neck cream to one randomized side and placebo to the contralateral side twice daily for 8 weeks. Wrinkles/roughness, elasticity, and sagging were instrumentally quantified at baseline and weeks 2, 4, and 8. MK-7 increased ATP production, elevated the NAD+/NADH ratio, restored ΔΨm, preserved mtDNA copy number under oxidative challenge, enhanced activities of multiple respiratory complexes, and reduced UVA-induced SASP marker expression. In human efficacy evaluations, MK-7 produced significant improvements versus placebo in wrinkle roughness on face and neck, improved elasticity parameters, and attenuated sagging over 8 weeks. MK-7 was associated with improved mitochondrial bioenergetic readouts in vitro and measurable anti-aging effects in a split-face/neck study, supporting further development of mitochondrial targeting approaches for skin aging.

ACS Omega
Nanjing Tech University (CN), Cosmetics Europe (BE), Luye Pharma (China) (CN), Mercy Medical Center Merced (US)
Affordable and clean energy
Openalex Percentile: Top 10%
Vitamin K Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.